Proposed mechanisms of Tesamorelin: Activates GHRH receptors Increases endogenous GH release Elevates IGF-1 production Promotes lipolysis Reduces visceral adipose tissue Why Tesamorelin is unique: Unlike most weight-loss therapies, Tesamorelin appears particularly effective at reducing visceral fat the deep abdominal fat surrounding internal organs that is strongly associated with insulin resistance, cardiovascular disease, and metabolic syndrome
Less than 1.20 AU/mL is considered negative and more than 1.53 AU/mL is positive for IF antibodies
Highlights CPT codes used for office visits, hospital care, preventive services, and patient monitoring Billing guidance for chronic care management and transitional care services Common modifier usage for procedures, preventive visits, and telehealth billing 2026 coding updates related to RPM, RTM, and immunization reporting Correct CPT code selection affects claim accuracy, reimbursement, and compliance
Warnings Avoid the intravenous route